| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |